Stonebridge Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,190
| Closed | -$201K | – | 115 |
|
|
2019
Q3 | $201K | Sell |
1,190
-390
| -25% | -$65.9K | 0.09% | 111 |
|
|
2019
Q2 | $290K | Sell |
1,580
-925
| -37% | -$170K | 0.11% | 96 |
|
|
2019
Q1 | $461K | Hold |
2,505
| – | – | 0.17% | 89 |
|
|
2018
Q4 | $415K | Sell |
2,505
-57
| -2% | -$9.44K | 0.17% | 88 |
|
|
2018
Q3 | $494K | Sell |
2,562
-1,160
| -31% | -$224K | 0.17% | 83 |
|
|
2018
Q2 | $630K | Hold |
3,722
| – | – | 0.23% | 72 |
|
|
2018
Q1 | $601K | Hold |
3,722
| – | – | 0.22% | 74 |
|
|
2017
Q4 | $588K | Sell |
3,722
-225
| -6% | -$35.5K | 0.21% | 77 |
|
|
2017
Q3 | $600K | Sell |
3,947
-25
| -0.6% | -$3.8K | 0.23% | 74 |
|
|
2017
Q2 | $512K | Sell |
3,972
-1,809
| -31% | -$233K | 0.2% | 79 |
|
|
2017
Q1 | $633K | Sell |
5,781
-1,100
| -16% | -$120K | 0.26% | 68 |
|
|
2016
Q4 | $507K | Buy |
+6,881
| New | +$507K | 0.21% | 74 |
|